Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human interferon-beta therapy for cerebral primitive neuroectodermal tumors--two case reports

S Tanaka1, M Okada, M Murakami

  • 1Department of Neurosurgery, Ichihara Hospital, Teikyo University School of Medicine, Chiba, Japan.

Neurologia Medico-Chirurgica
|February 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Current status of integrating oncology and palliative care in Japan: a nationwide survey.

BMC palliative care·2020
Same author

Interleukin-25 is involved in cutaneous T-cell lymphoma progression by establishing a T helper 2-dominant microenvironment.

The British journal of dermatology·2017
Same author

Fucosylated TGF-β receptors transduces a signal for epithelial-mesenchymal transition in colorectal cancer cells.

British journal of cancer·2013
Same author

Halothane augments the interaction between succinylcholine and pancuronium.

Journal of anesthesia·2013
Same author

Can a belly board reduce respiratory-induced prostate motion in the prone position?--assessed by cine-magnetic resonance imaging.

Technology in cancer research & treatment·2013
Same author

The endoscopic diagnosis of nonerosive reflux disease using flexible spectral imaging color enhancement image: a feasibility trial.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2011

Human fibroblast interferon (HuIFN-beta) shows promise in treating recurrent pediatric primitive neuroectodermal tumors (PNET). This interferon therapy may offer an effective, low-side-effect option for long-term PNET maintenance.

Area of Science:

  • Pediatric Oncology
  • Immunotherapy
  • Neuro-oncology

Background:

  • Recurrent pediatric primitive neuroectodermal tumors (PNET) present significant treatment challenges.
  • Limited effective long-term maintenance therapies exist for PNET.

Observation:

  • Two pediatric patients with recurrent PNET received intravenous human fibroblast interferon (HuIFN-beta).
  • Treatment was continued as outpatient maintenance therapy.

Findings:

  • Both patients demonstrated a partial response to HuIFN-beta therapy.
  • Patients remained alive 14 months and 2 years post-diagnosis, indicating sustained efficacy.

Implications:

  • HuIFN-beta may be an effective therapeutic option for pediatric PNET.

Related Experiment Videos

  • This immunotherapy can potentially be used for long-term PNET maintenance with minimal adverse effects.